The mAbs showed a trend toward better potency against psVs with chronic Envs (AUC = 0.12 to 0.54; median = 0.30) than against acute Envs (AUC = 0.10 to 0.46; median = 0.23); this difference did not reach statistical significance.
← all excerpts
Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes.
1
—
—